Dr. Adrien NIVOLIEZ (PhD) is General Manager at biose® in charge of the activities of Research and Development. He has worked for the pharmaceutical company for the last 10 years, starting out in industrial/production areas and now heads up Research and Development. He has developed expertise in probiotics / Live Biotherapeutic Products from this time with the company, and more particularly the impact of industrial processes on the therapeutic potential of a probiotic strain. To treat the dysbiosis of the human microbiota, probiotics have historically been the first approach, and their development must include these industrial parameters. Also, current research opens up new opportunities in the field of biotechnology and bioproduction. The goal of this decade will be to offer new therapeutic opportunities. The mission of biose® is to develop the best therapeutic microbiotic ranges for human health. We seek to treat people differently, focusing on their microbiome.